Sign inJoin waitlistJoin the waitlist

TV

Timothy Vollmer

Psychiatry & Neurology / Neurology

Credentials: · · ·

History

Neurology
1986–1990
Stanford University School of Medicine
1978–1982

Research

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
New England Journal of Medicine · 2008 · 1,936 citations
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial
Annals of Neurology · 2009 · 724 citations
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Neurology · 2014 · 693 citations

DC
Denise Campagnolo
31 papers
John Corboy
21 papers
KN
Kavita Nair
20 papers
RM
Ruth Marrie
19 papers
Enrique Alvarez
18 papers
GC
Gary Cutter
17 papers
Jeffrey Cohen
10 papers
AC
Antonio La Cava
8 papers
HP
Hillel Panitch
8 papers
Amit Bar-Or
7 papers
Ralph Horwitz
7 papers
JP
Jana Preiningerova
6 papers

Clinical trials

Home Based Infusions for Ocrelizumab
Principal investigator · Recruiting · Phase 4
University of Colorado, Denver
2021
Safety of Switching From Rituximab to Ocrelizumab in MS Patients
Principal investigator · Completed · Phase 3
University of Colorado, Denver
2017–2019
Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate
Principal investigator · Completed · Phase 2
University of Colorado, Denver
2012–2015
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Principal investigator · Terminated · Phase 3
Teva Branded Pharmaceutical Products R&D, Inc.
2010–2017